Piper Jaffray to Host 28th Annual Healthcare Conference
November 15 2016 - 2:25PM
Business Wire
Piper Jaffray Companies (NYSE: PJC), a leading investment bank
and asset management firm, will host its 28th annual Healthcare
Conference in New York on November 29-30, 2016.
The Piper Jaffray Healthcare Conference will showcase senior
management teams from nearly 300 leading public and private
companies delivering presentations to an audience of nearly 2,000,
including institutional investors, equity portfolio managers and
research analysts. The two-day event will also host more than 3,600
private one-on-one meetings with company management. Presenting
companies represent several healthcare sectors, including:
biotechnology, medical services, specialty pharmaceuticals, medical
technology, and life sciences tools and diagnostics.
Highlighting the conference will be several panel discussions
featuring industry experts, physicians and academicians moderated
by Piper Jaffray healthcare senior research analysts:
- Underdiscovered Neuro-Innovators
PanelModerated by Charles Duncan, Ph.D.
- Political PanelModerated by Matt
O’Brien, Bill Quirk and Brooks West
- Oncolytic Virus Panel: Gene Therapy
Meets Cancer Immunotherapy PanelModerated by Josh Schimmer,
M.D.
- Underdiscovered Platform-Enabled
Drug Developers PanelModerated by Charles Duncan, Ph.D.
- Gene Therapy: The NAV Masters
PanelModerated by Josh Schimmer, M.D.
- Genomics 3.0: The Third Wave of Gene
Targeting Therapies is Coming PanelModerated by Josh Schimmer,
M.D.
- Healthcare Executive
PanelModerated by Matt O’Brien and Brooks West
“As a frontrunner in the healthcare industry, our goal at the
conference is to help investors navigate this evolving sector in
the context of a regulatory and market landscape that continues to
shift,” said Michael Cox, director of equity research at Piper
Jaffray. “By bringing together hundreds of leading healthcare
companies, we are able to provide our clients with a unique and
exclusive experience.”
Follow the conversation using the event hashtag #PJCHCC16
Company and investor participation in the conference is by
invitation only. Clients interested in attending should contact
their Piper Jaffray representative. General and research-related
media inquiries should be directed to
analystmediarelations@pjc.com. All other media inquiries should be
directed to Pamela Steensland at pamela.k.steensland@pjc.com.
Information as of November 14, 2016. Subject to change.
About Piper JaffrayPiper Jaffray Companies (NYSE: PJC) is
a leading investment bank and asset management firm. Securities
brokerage and investment banking services are offered in the U.S.
through Piper Jaffray & Co., member SIPC and FINRA; in Europe
through Piper Jaffray Ltd. and Simmons & Company International
Limited, authorized and regulated by the U.K. Financial Conduct
Authority; and in Hong Kong through Piper Jaffray Hong Kong
Limited, authorized and regulated by the Securities and Futures
Commission. Asset management products and services are offered
through five separate investment advisory affiliates―U.S.
Securities and Exchange Commission (SEC) registered Advisory
Research, Inc., Piper Jaffray Investment Management LLC, PJC
Capital Partners LLC and Piper Jaffray & Co.; and
Guernsey-based Parallel General Partners Limited, authorized and
regulated by the Guernsey Financial Services Commission.
© 2016 Piper Jaffray Companies. 800 Nicollet Mall, Suite
1000, Minneapolis, Minnesota 55402-7036
Follow Piper Jaffray: LinkedIn | Facebook | Twitter
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161115006621/en/
Piper Jaffray CompaniesPamela Steensland,
612-303-8185pamela.k.steensland@pjc.com
Piper Jaffray Companies (NYSE:PJC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Piper Jaffray Companies (NYSE:PJC)
Historical Stock Chart
From Apr 2023 to Apr 2024